How many institutions held HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share in Q2 2022?

85 institutional investors reported HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share for Q2 2022. Use the holders table for investor-level position and value details.

HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO)

Q: What does CUSIP 416906105 represent in this 13F holders report?

CUSIP 416906105 is the security identifier for HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

CUSIP: 416906105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 5,297,433
Total 13F shares: 29,663,685
Share change: -423,841
Total reported value: $106,795,432
Price per share: $3.60
Number of holders: 85
Value change: -$4,430,704
Number of buys: 45
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 416906105?
CUSIP 416906105 identifies HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 416906105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HBIO - HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	58%	3,058,002	$18,990,000	—	31 Mar 2022	13F
Portolan Capital Management, LLC	13F	Company	48%	2,526,789	$15,691,000	—	31 Mar 2022	13F
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	13F	Company	47%	2,465,410	$15,310,000	—	31 Mar 2022	13F
Harvey Partners, LLC	13F	Company	42%	2,226,000	$13,823,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	36%	1,924,517	$11,952,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	35%	1,878,050	$11,663,000	—	31 Mar 2022	13F
ROYCE & ASSOCIATES LP	13F	Company	32%	1,685,963	$10,470,000	—	31 Mar 2022	13F
Granahan Investment Management, LLC	13F	Company	27%	1,456,749	$9,046,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	20%	1,067,314	$6,626,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	18%	948,445	$5,890,000	—	31 Mar 2022	13F
272 Capital LP	13F	Company	17%	898,436	$5,579,000	—	31 Mar 2022	13F
AMH Equity Ltd	13F	Company	15%	776,253	$4,821,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	14%	742,929	$4,614,000	—	31 Mar 2022	13F
Archon Capital Management LLC	13F	Company	13%	686,236	$4,262,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	12%	649,325	$4,032,000	—	31 Mar 2022	13F
Parkman Healthcare Partners LLC	13F	Company	12%	633,826	$3,936,000	—	31 Mar 2022	13F
Meros Investment Management, LP	13F	Company	9.9%	525,586	$3,263,000	—	31 Mar 2022	13F
Monarch Partners Asset Management LLC	13F	Company	9.3%	493,202	$3,063,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	8.6%	456,484	$2,834,000	—	31 Mar 2022	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	8.2%	431,848	$2,682,000	—	31 Mar 2022	13F
HEARTLAND ADVISORS INC	13F	Company	7.6%	400,000	$2,484,000	—	31 Mar 2022	13F
BARD ASSOCIATES INC	13F	Company	5.5%	290,197	$1,802,000	—	31 Mar 2022	13F
GLOBEFLEX CAPITAL L P	13F	Company	5.1%	268,466	$1,667,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	5%	266,192	$1,654,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	5%	266,314	$1,653,000	—	31 Mar 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	4.3%	225,517	$1,400,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	4.2%	224,606	$1,395,000	—	31 Mar 2022	13F
GREENWOOD CAPITAL ASSOCIATES LLC	13F	Company	4.2%	222,979	$1,385,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	3.2%	166,956	$1,037,000	—	31 Mar 2022	13F
Kenneth Fletcher Olson	3/4/5	Chief Operating Officer	— class O/S missing	155,595	$832,433	—	29 Dec 2021	3/4/5
Pasadena Private Wealth, LLC	13F	Company	2.2%	117,301	$728,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	2.2%	115,613	$718,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	2.2%	114,000	$707,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	2.1%	112,892	$701,000	—	31 Mar 2022	13F
ClariVest Asset Management LLC	13F	Company	2%	108,301	$672,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	1.9%	101,175	$600,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.8%	93,736	$583,000	—	31 Mar 2022	13F
Riverwater Partners LLC	13F	Company	1.8%	93,143	$578,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	1.7%	87,899	$546,000	—	31 Mar 2022	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	1.5%	79,241	$492,000	—	31 Mar 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	1.5%	77,034	$478,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	76,553	$475,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	1.4%	74,848	$465,000	—	31 Mar 2022	13F
Trexquant Investment LP	13F	Company	1.2%	63,189	$392,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	1.1%	60,000	$373,000	—	31 Mar 2022	13F
Engineers Gate Manager LP	13F	Company	1.1%	59,738	$371,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.99%	52,688	$327,000	—	31 Mar 2022	13F
Penbrook Management LLC	13F	Company	0.94%	50,000	$311,000	—	31 Mar 2022	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.92%	48,695	$302,000	—	31 Mar 2022	13F
Bollard Group LLC	13F	Company	0.88%	46,485	$289,000	—	31 Mar 2022	13F

Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) as of Q2 2022

As of 30 Jun 2022, HARVARD BIOSCIENCE INC - Common Stock, par value $0.01 per share (HBIO) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,663,685 shares. The largest 10 holders included Harvey Partners, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., Portolan Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, B. Riley Asset Management, LLC, VANGUARD GROUP INC, Granahan Investment Management, LLC, AMH Equity Ltd, and BlackRock Inc.. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-11

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.